0001209191-21-056459.txt : 20210916
0001209191-21-056459.hdr.sgml : 20210916
20210916181601
ACCESSION NUMBER: 0001209191-21-056459
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210914
FILED AS OF DATE: 20210916
DATE AS OF CHANGE: 20210916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brinkley Ruth Williams
CENTRAL INDEX KEY: 0001344381
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36257
FILM NUMBER: 211258833
MAIL ADDRESS:
STREET 1: C/O TRAVERE THERAPEUTICS, INC.
STREET 2: 3611 VALLEY CENTRE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER NAME:
FORMER CONFORMED NAME: Brinkley Ruth W
DATE OF NAME CHANGE: 20051114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Travere Therapeutics, Inc.
CENTRAL INDEX KEY: 0001438533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262383102
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DR
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 888-969-7879
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DR
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Retrophin, Inc.
DATE OF NAME CHANGE: 20130220
FORMER COMPANY:
FORMER CONFORMED NAME: Desert Gateway, Inc.
DATE OF NAME CHANGE: 20080625
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-14
0
0001438533
Travere Therapeutics, Inc.
TVTX
0001344381
Brinkley Ruth Williams
C/O TRAVERE THERAPEUTICS, INC.
3611 VALLEY CENTRE DRIVE, SUITE 300
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2021-09-14
4
A
0
5250
0.00
A
5250
D
Stock Option (Right to Buy)
23.61
2021-09-14
4
A
0
15750
0.00
A
2031-09-13
Common Stock
15750
15750
D
One-third of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 24 equal monthly installments thereafter.
/s/ Elizabeth E. Reed, Attorney-in-Fact
2021-09-16